A drug with the SMILES CCNc1nc(NCC)n2c(SC(C(=O)Nc3cc(C)ccc3OC)c3ccccc3)nnc2n1 has a hERG inhibition at a concentration of 10uM of -41.353%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCNc1nc(NCC)n2c(SC(C(=O)Nc3cc(C)ccc3OC)c3ccccc3)nnc2n1
CCNc1nc(NCC)n2c(SC(C(=O)Nc3cc(C)ccc3OC)c3ccccc3)nnc2n1
2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-(2-methoxy-5-methylphenyl)-2-phenylacetamide